Pacific BioLabs is a life science testing services company focusing on regulatory compliance and quality systems for the pharmaceutical, biopharmaceutical, and medical device industries.

Pacific BioLabs

Pacific BioLabs is the leading West Coast provider of GMP/GLP laboratory testing services supporting Medical Device, Pharmaceutical, and Biotechnology industries. As a CRO, we offer toxicology, biocompatibility, microbiology, sterility assurance, and analytical chemistry testing and research support services.

Pacific BioLabs’ mission is to contribute to the development of safe and efficacious medical products while maintaining rigorous scientific integrity and the highest standards of regulatory quality. We have a strong commitment to confidentiality, impartiality, and continuous quality improvement.

As The Service Leader in Life Science Testing, Pacific BioLabs continuously strives to meet and exceed client deadlines and offers personalized, proactive, and friendly client service.

Pacific BioLabs, Inc.

Pacific BioLabs is happy to announce our ISO 17025 accreditation is now being managed and overseen by the American Association for Laboratory Accreditation (A2LA). A2LA is among the largest accreditation bodies in the world and is a leader in the formal recognition of competent testing laboratories according to ISO 17025. A2LA’s core values of Quality, Integrity, Community, Accountability, and Leadership align with the core values of Pacific BioLabs’ Quality Policy. We are looking forward to a long-term relationship with A2LA as Pacific BioLabs accreditation body. For more information, please contact us at this link - https://lnkd.in/gphGYQzS

There are no changes to the scope and our accreditation was seamlessly transitioned to A2LA. If you have a Pacific BioLabs ISO 17025 accreditation certificate within your vendor files, please replace it with the current valid certificate found here - https://lnkd.in/gk5mBkfm

Outsourcing, including preclinical testing, is becoming increasingly common in the biopharmaceutical industry. It can be a daunting process to choose the most appropriate preclinical testing laboratory or CRO for your outsourced studies but Pacific BioLabs’ Director of Business Development, Daniel Radiloff, has provided a resource guide of this process which can be accessed in the BioPharm International digital eBook here:     
BioPharm International - May 2024 - BioPharm International - May 2024 https://lnkd.in/dteZ9uvp?. 
#outsourcing #cro

PACIFIC BIOLABS INTRODUCES ENVIRONMENTAL MONITORING TESTING

Did you know that as of November 1 2023, USP <797> "Pharmaceutical Compounding - Sterile Preparations" was revised to provide stricter guidelines for the preparation of compounded sterile preparations (CSP)? This includes more detailed language on the frequency of sampling of personnel and of the cleanroom environment. It also provides more regulations on aseptic manipulation and media fill testing. Pacific BioLabs has launched their new environmental monitoring service to help you navigate these new standards and provide comprehensive testing under these guidelines including microbiological air and surface monitoring along with testing of media fill containers. 
If you would like to learn more on how Pacific BioLabs may support your environmental monitoring as well as other microbiology testing programs, please feel free to contact Daniel Radiloff, or fill out our Contact Form at https://lnkd.in/gphGYQzS.

Pacific BioLabs CEO Michael Spalding and COO Mike Yakes were honored to receive the 25 Year SOT Exhibitor Award presented by SOT President Dr. Dori Germolec. If you are at the 63rd SOT Annual Meeting this week, please visit Booth 1814 to speak with Daniel Radiloff and our scientific team — they would be more than happy to help you with any questions you may have regarding our in vitro and in vivo toxicological testing services.

#2024SOT #ToxExpo #pacificbiolabs

If you are attending the 63rd SOT Annual Meeting next week, please visit the Pacific BioLabs exhibition Booth 1814 to speak with our Director of Business Development Daniel Radiloff and our scientific team — they would be more than happy to help you with any questions you may have regarding our in vitro and in vivo toxicological testing services. You can also reach out to them directly to schedule a consultation. 

#2024SOT #ToxExpo #pacificbiolabs

Pacific BioLabs is excited to be participating as an exhibitor at the Society of Toxicology (SOT) Annual Meeting and ToxExpo in Salt Lake City, Utah on March 11 – 13, 2024. This marks Pacific BioLabs’ 25th year as an exhibitor at this event. To learn more about Pacific BioLabs and our services related to toxicological testing, please visit Booth 1814. We look forward to meeting with our current and prospective partners. 

#2024SOT #ToxExpo #pacificbiolabs

Metric
Company Name	Pacific BioLabs
Symbol
MSH ID	COM:PACIFICBIOLABS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Life Science Testing Services
Country	US
Stage
Employee Count	121
Website	pacificbiolabs.com
LinkedIn	pacific-biolabs
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PACI

COM:PACIFICBIOLABS

Pacific BioLabs

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue